BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22841285)

  • 1. Inhibition of experimental neointimal hyperplasia and neoatherosclerosis by local, stent-mediated delivery of everolimus.
    Zhao HQ; Nikanorov A; Virmani R; Schwartz LB
    J Vasc Surg; 2012 Dec; 56(6):1680-8. PubMed ID: 22841285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
    Buszman PP; Milewski K; Pająk J; Jelonek M; Orlik B; Krauze A; Gwiazdowska-Nowotka B; Wojakowski W; Tellez A; Granada JF; Buszman PE
    EuroIntervention; 2014 Oct; 10(6):724-31. PubMed ID: 24469344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of long-term implantation of BuMA stent in a porcine coronary model.
    Chen M; Wang XG; Zheng B; Peng HY; Zhang XY; Zhang B; Huo Y
    Chin Med J (Engl); 2012 Nov; 125(22):4083-7. PubMed ID: 23158147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery.
    Conway C; Desany GJ; Bailey LR; Keating JH; Baker BL; Edelman ER
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):278-285. PubMed ID: 30244502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
    Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
    EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental evaluation of efficacy and healing response of everolimus-eluting stents in the familial hypercholesterolemic swine model: a comparative study of bioabsorbable versus durable polymer stent platforms.
    Tellez A; Seifert PS; Donskoy E; Sushkova N; Pennington DE; Milewski K; Krueger CG; Kaluza GL; Eppihimer MJ; Huibregtse BA; Dawkins KD; Granada JF
    Coron Artery Dis; 2014 May; 25(3):198-207. PubMed ID: 24642807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stents coated with sirolimus and anti-CD34 antibody can optimize the performance of sirolimus-eluting stents].
    Song XT; Zhu HG; Yang XS; Yuan F; Lü SZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov; 39(11):997-1004. PubMed ID: 22336451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
    Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
    J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of below-the-knee drug-eluting stents with frequency-domain optical coherence tomography: neointimal hyperplasia and neoatherosclerosis.
    Paraskevopoulos I; Spiliopoulos S; Davlouros P; Karnabatidis D; Katsanos K; Alexopoulos D; Siablis D
    J Endovasc Ther; 2013 Feb; 20(1):80-93. PubMed ID: 23391087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.
    Hoymans VY; VAN Dyck CJ; Haine SE; Frederix G; Fransen E; Timmermans JP; Vrints CJ
    J Interv Cardiol; 2014 Aug; 27(4):381-90. PubMed ID: 24815761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolute and Xience V polymer-based drug-eluting stents compared in an atherosclerotic rabbit double injury model.
    Van Dyck CJ; Hoymans VY; Bult H; Fransen E; Haine S; Bosmans JM; Timmermans JP; Vrints CJ
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):E259-68. PubMed ID: 22887820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of local heating on restenosis and in-stent neointimal hyperplasia in the atherosclerotic rabbit model: a dose-ranging study.
    Brasselet C; Durand E; Addad F; Vitry F; Chatellier G; Demerens C; Lemitre M; Garnotel R; Urbain D; Bruneval P; Lafont A
    Eur Heart J; 2008 Feb; 29(3):402-12. PubMed ID: 18212388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.
    Goto K; Zhao Z; Matsumura M; Dohi T; Kobayashi N; Kirtane AJ; Rabbani LE; Collins MB; Parikh MA; Kodali SK; Leon MB; Moses JW; Mintz GS; Maehara A
    Am J Cardiol; 2015 Nov; 116(9):1351-7. PubMed ID: 26341188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.